News

Opinion
Trump's attacks on Powell pose another risk for bondholders - especially older investors
The bad news is that President Donald Trump's latest threats against the independence of the Federal Reserve raise the risks to your investments. The threats themselves are bad enough. But the ...
Trump won't fire Powell - but he could still pressure the Fed, says economist studying president's tweets
President Donald Trump is unlikely to follow through on his threat to fire Federal Reserve Chairman Jerome Powell - but the pressure from his public campaign for lower interest rates will still have ...
Trump's trade war: Which countries are in tariff talks with the U.S. - and what could come next
Trump has slapped 25% tariffs on goods from both Mexico and Canada, but later suspended those levies on products that fall under the two countries' trade agreement with the U.S. Still, many products ...
Why Trump Media once again called out 'naked short selling' as its stock dropped
The parent company of President Donald Trump's social-media platform, Truth Social, is on the warpath against "naked short selling" again as its stock has fallen, this time directing its sniping at a ...
The 'smart money' investors are buying stocks here, according to this index. It could be an opportunity.
If the recent past is any guide, an indicator known as the "Smart Money Flow Index" might be flashing a market buy signal, said Jim Paulsen, a market veteran and former top strategist at the Leuthold ...
Eli Lilly's stock soars as successful trial of weight-loss pill is a game changer
Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...
Silver could finally be a better investment opportunity than gold, some analysts say
Ahead of that announcement, most commodities, including gold and silver, were trading higher as speculators expected the tariffs to prove inflationary, Ash said. But the "reality of Trump's tariff war ...
Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSU
Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...
Why Meta is one of the most compelling tech stocks right now
Meta (META) has the second-lowest forward P/E among the largest 10 components of the S&P 500. Only Alphabet Inc. (GOOGL) trades lower. The Google holding company faces its own antitrust challenges, ...
Not even the co-creator of this economic-uncertainty index can tell when the worst will be over
It had become something of a cliché to say that investors hate uncertainty - at least until the confusion surrounding President Donald Trump's on-again, off-again tariff plans left them grasping for a ...
Not even the co-creator of this -2-
Economic-policy uncertainty has "gone parabolic since the start of the year, and the likelihood of a continued parabolic trend is pretty low compared to the likelihood that we will revert back to some ...
Nintendo isn't raising the price of the Switch 2 or 'Mario Kart World' over Trump tariffs - for now
Gamers got a classic "good news, bad news" announcement on Good Friday.